Introduction

H
earing loss is one of the most common afflictions in the world, affecting about one in every 1000 newborns (Petersen and Willems, 2006) . Provision of specialized care and education to those children require a significant amount of resources and dedication. In addition, the social stigma usually associated with a deaf child may affect his or her response to treatment or care. Genetic factors are estimated to be the underlining cause of more than half of the hearing loss cases, which means that deafness is hereditary in a significant proportion in any given population. Hereditary hearing loss can be associated with syndromes affecting other functions of the body. However, the majority of hearing loss cases is not associated with syndromes (nonsyndromic) that can be transmitted in an autosomal recessive, autosomal dominant, or X-linked modes of inheritance (Petersen and Willems, 2006) . Autosomal recessive hereditary nonsyndromic hearing loss (the most common type of hereditary hearing loss) can be caused by mutations affecting any one of the 62 deafness loci identified so far, thus making NSHL a very heterogenous trait and complicating diagnosis and genetic counseling (Hilgert et al., 2009) . However, on average, at least half of the NSHL cases are caused by mutations in the GJB2= CONNEXIN26 gene (Hereditary Hearing Loss Home Page, http:==webh01.ua.ac.be=hhh=). This places GJB2 as the prime suspect and the first candidate NSHL-causing gene to be analyzed when studying the molecular etiology of deafness in any new ethnic population (Hilgert et al., 2009) .
GJB2=CONNEXIN26 is a member of a large family of gab junction proteins that function in mediating cell-to-cell contact and communication. Located at chromosome 13q12.11, GJB2 is a relatively small gene with two exons and one intron and the entire coding region is comprised only of exon 2 (Martinez et al., 2009) . Mutations in GJB2 account for up to 50% of NSHL cases in Europe and the United States, with a single mutation (c.35delG) accounting for at least one-third of those cases (Gasparini et al., 2000; Lucotte and Mercier, 2001; Minarik et al., 2003; Roux et al., 2004; Lucotte and Dieterlen, 2005; Putcha et al., 2007) . Relatively high frequencies of GJB2 mutations, other than c.35delG, have been reported for other ethnic populations, including c.235delC in Japanese (Abe et al., 2000) , p.Arg143Trp in Africans (Brobby et al., 1998) , and c.167delT in Ashkenazi Jews, indicating founder events (Morell et al., 1998) . Interestingly, in Lebanon, GJB2 mutation levels and type (c.35delG) are equivalent to that in western Europe (Mustapha et al., 2001) . This observation supports the founder effect of the c.35delG mutation, considering a recent paper on the genetic backgrounds of the Lebanese population showing that a significant percentage has southern=western European origins (Zalloua et al., 2008) .
Consanguineous marriages are frequent in Saudi Arabia; over half of the marriages are between related partners, often first-cousin relatives (El Mouzan et al., 2008) . Consanguinity can exacerbate the frequency of genetic diseases and it is also expected to do so in hereditary deafness. The prevalence of hearing impairment was significantly higher in children whose parents were either first cousins or relatives when compared with the children whose parents were not related, thus demonstrating a definite role of consanguinity in the etiology of childhood hearing impairment in Saudi Arabia ( Jamal et al., 2002) . In the neighboring Sultanate of Oman, 70% of the deaf children were born to parents of consanguineous marriages (Khabori and Patton, 2008) . GJB2 mutations were ruled out as a cause of hereditary NSHL in Oman (Simsek et al., 2001) , making genetic counseling for hearing loss a difficult task to accomplish.
The objective of this study was to determine the frequency and spectrum of GJB2 mutations in the Saudi population, particularly from the ethnically mixed western region of the Kingdom of Saudi Arabia. The overall aim was to understand the molecular etiology of NSHL in this region, to be able to offer genetic counseling to the affected families and aid in the care of the hearing-impaired individuals.
Materials and Methods
Samples from patients with NSHL were collected following the appropriate local ethical protocols and guidelines from the Audiology Clinic of the King Abdulaziz University Hospital in Jeddah or the Audiology Department of the Jeddah Institute for Speech and Hearing as well as from the Al-Amal Institute for the Deaf in Jeddah. Genomic DNA was prepared from peripheral blood isolated from the subjects using the Qiagen (Valencia, CA) Blood DNA extraction kit according to the manufacturers' protocol. In addition, DNA obtained from 37 apparently normal hearing subjects was also used to determine the carrier frequency for GJB2 mutations. GJB2 exon 1 was amplified using a forward primer (5 0 -CGTAACTTTCCC AGTCTCCG-3 0 ) and reverse primer (5 0 -CCAAGGACGTGT GTTGGTC-3 0 ), generating a 358-bp polymerase chain reaction (PCR) product. GJB2 exon 2 was amplified using forward primer (5 0 -AGATTTAAGCATGCTTGCTTAC-3 0 ) and reverse primer (5 0 -CTCATGCTGTCTATTTCTTAATCTAA-3 0 ), generating an 838-bp PCR product. The PCR conditions used for the amplification of either exon 1 or exon 2 were one denaturation cycle at 958C for 15 min followed by eight touchdown cycles of denaturation at 958C for 30 s, and annealing for 30 s at 608C for the first two cycles and a 28C reduction every two cycles. This is followed by 35 cycles of denaturation at 958C for 30 s, and annealing at 538C for 30 s and extension at 728C for 1 min. The final extension step was done at 728C for 10 min. The MgCl 2 concentrations used for the amplification of exon 1 and exon 2 were 3 and 5 mM, respectively. In addition, the exon 1 amplification reaction was aided by the addition of 15% glycerol. All PCR reactions were performed using the Qiagen HotStarTaq DNA Polymerase on the Bio-Rad MyCycler thermal cycler (Bio-Rad, Hercules, CA). The PCR products were purified using the GFX columns (GE Healthcare, Little Chalfont, United Kingdom) prior to performing the cycle sequencing reaction using the ABI BigDye v3.1 and the ABI 3130 capillary DNA analyzer (ABI, Foster City, CA). For the detection of the D(GJB6-D13S1830), we used the primers GJB6-1R (5 0 -TTTAGGGCATGATTGGGGTGATTT-3 0 ) and reverse primer BKR-1 (5 0 -CACCATGCGTAGCCTTAACCATTTT-3 0 ) using the conditions reported by del Castillo et al. (2002) . A positive sample for the deletion, kindly provided by Dr. del Castillo and Dr. Guy Van Camp, was used as a positive control.
Results
We have obtained informative DNA sequencing data from 109 individuals. GJB2 was amplified by PCR and subjected to automated DNA sequencing for affected individuals, followed by confirmation of the presence of the mutation in the parents and siblings where available. Twelve genetic variations in the GJB2 sequence were found in 17 members of our cohort. Eleven patients with NSHL exhibited biallelic GJB2 mutations, whereas six were found to have monoallelic GJB2 variations. The mutations found were all previously reported ( Fig. 1 and Table 1 ). The common, biallelic c.35delG mutation routinely found in patients of southern European or Mediterranean origins was found in seven patients in our cohort who were diagnosed with profound NSHL. The p.Trp24X truncation mutation, which is common in India and in the Gypsy population, was found in one patient with profound NSHL from our cohort. In addition, another patient exhibited compound heterozygote missense changes (c.11G>A, p.Gly4Asp and c.109G>A, p.Val37Ile). However, this patient suffered mild NSHL. A biallelic c.-34C>T change in the 5 0 -UTR was found in two unrelated patients. However, one of these patients (and his brother) had a homozygous p.Trp77Arg mutation. A p.Glu47X nonsense mutation was found in one patient but in a heterozygous state. A heterozygous c.-6T>A change in the 5 0 -UTR of GJB2 was detected in one family, with the father, three boys, and one girl all exhibiting the same change. Despite this mutation, the father was found to have apparently normal hearing. A heterozygous c.-3179G>A splice site mutation in the first intron was detected in one patient with profound hearing loss. A monoallelic change at c.487A>G, p.Met163Val was detected in one patient, whereas another exhibited a c.35G>T, p.Gly12Val substitution as opposed to deletion. We could not detect the D(GJB6-D13S1830) mutation in our cohort. When consanguinity was examined, consanguineous marriages were the case for 8 out of 10 affected families. In addition, 2 AL-QAHTANI ET AL.
another family had a same-tribe marriage. Taken together, GJB2 mutations were detected in 17 unrelated deafness cases out of 109 (15.59%). Biallelic mutations, which are more likely to be the underlying cause of deafness, were detected in 11=109 (10.09%). The homozygous c.35delG mutation was found in 7=11 affected individuals (63.63%). For genotype-phenotype correlation, all the biallelic mutations identified were associated with profound hearing loss, with the exception of compound heterozygous p.Gly4Asp and p.Val37Ile which were associated with mild hearing loss only. The c.35delG mutation was found in the monoallelic state in 2 out of 37 individuals with apparently normal hearing (5.4%). The p.Val27Ile SNP was also identified in the heterozygous state in 2 out of 37 individuals with apparently normal hearing (5.4%). These two mutations were found in the same patient. These two mutations were found in the same patient. NSHL, nonsyndromic hearing loss.
FIG. 1.
Sequence chromatographs of the GJB2 sequence variants identified in our cohort. Nucleotide numbering is based on the ATG translation start site, with A considered as þ1. Arrows indicate the site of nucleotide change.
GJB2 MUTATIONS IN SAUDI ARABIADiscussion and Conclusion
There is an increasing demand for genetic testing of hereditary hearing loss among the population of Saudi Arabia. Lack of information about the genetic factors that predispose to NSHL in this population have so far hindered offering this service as part of the tasks of molecular diagnostic and genetic testing centers. Therefore, we have undertaken this study to examine the spectrum and frequency of mutations in the GJB2=DFNB1 locus in the Saudi population to aid genetic counseling for families with NSHL as well as early intervention when inactivating mutations are discovered in newborns. According to our analysis, GJB2 biallelic mutation frequency in the western region of the Kingdom of Saudi Arabia is estimated to be 10.09%. This frequency is more in line with the GJB2 mutation frequency in non-European populations. However, the mutations found give a snapshot of the genetic heterogeneity of the urban population of the western province of Saudi Arabia caused by centuries of Hajj pilgrimage migration as well as economic migration and settlement in the port city of Jeddah and the surrounding areas from around the world. The c.35delG mutation is thought to be of southern European origin, whereas the p.Trp24X is mostly found in the Indian and Gypsy populations (Bouwer et al., 2007) . The c.-6T>A and c.-34C>T variations have been previously detected in Sudan and Kenya (Gasmelseed et al., 2004) . The c.229C>T, p.Trp77Arg, was previously reported in Palestine (Carrasquillo et al., 1997) . Identifying a case with compound homozygous GJB2 mutations (-34C>T and p.Trp77Arg) is unusual and reflects either a case of chromosome 13 uniparental disomy (Yan et al., 2007) or an extreme case of consanguinity and multiple generations of in-breeding. Unfortunately, for such a case, DNA from parents was not available for this study. Our cohort consisted mainly of Saudi nationals (92=109) and the others were from Yemen (12=109), Pakistan (2=109), Oman (1=109), Palestine (1=109), and Egypt (1=109). The selection of the Saudi patients in our cohort was not biased toward any particular ethnic origin and we attempted to have a representative sample of the population in the area. Interestingly, only the heterozygous p.Glu47X and the p.Met163Val carriers belonged to a family from Arab tribal areas, which may indicate that another genetic factor(s) other than GJB2 is involved in causing the NSHL in the Arab tribal population. In addition, 5 out of 11 biallelic mutations identified were found in patients of Yemeni descent. This suggests that when deciding whether to screen a patient with hearing loss for GJB2 mutation, the ethnic origin should be taken into consideration, that is, patients from the Arab tribes are not likely to carry GJB2 mutations, whereas other Saudi patients of other ethnic origins, especially from Yemen or the Mediterranean, should be screened for GJB2 mutations. Unfortunately, determining the ethnic origin of Saudi patients remains a sensitive subject that should be approached with care and consideration on a case-by-case basis. GJB2 mutations were identified mostly in those patients with NSHL who had a family history of hearing loss and consanguineous marriages. Therefore, we recommend that NSHL sufferers be screened, along with their parents and siblings, for GJB2 mutations only when hereditary NSHL is indicated by family history and consanguinity. Carriers should be provided with genetic counseling to help them make informed decisions regarding family planning. This is the first published report on the genetic causes of NSHL in the Kingdom of Saudi Arabia. As GJB2 mutations are not the major underlining genetic cause of NSHL in Saudi Arabia, the search is currently on for identifying such factors in the local population which should aid the genetic testing and diagnosis of NSHL in this community.
